Lower numbers = closer to natural. Higher numbers = more enhanced.
Why this rating?
Metformin is an FDA-approved diabetes medication that improves insulin sensitivity through AMPK activation, not a performance enhancer. Per the MASTERS trial, it actually BLUNTS muscle hypertrophy gains from resistance training (and separate research links it to dampened aerobic adaptations). Used to manage blood sugar during HGH/insulin protocols, not to enhance performance. Not WADA prohibited. Rated 1 (basically natty) as it is a metabolic/organ-support medication with no path to raising your natural muscular or performance ceiling, if anything it works against hypertrophy adaptations, not toward them.
Overview
A biguanide antidiabetic drug that improves insulin sensitivity through AMPK activation. Used in bodybuilding to manage blood sugar during high-carb bulking phases and to counteract insulin resistance from HGH/insulin use. Also researched extensively for longevity/anti-aging applications (TAME trial). IMPORTANT: May blunt muscle hypertrophy adaptations from training.
Important Warnings
- •MASTERS trial showed metformin BLUNTS muscle hypertrophy from training
- •Prescription required - illegal to buy without prescription in USA
- •Annual B12 monitoring essential for long-term use
- •Contraindicated in renal impairment, liver disease, alcoholism
- •Stop before contrast imaging procedures (risk of lactic acidosis)
- •Does NOT cause hypoglycemia when used alone
- •GI side effects common initially - start low and titrate
- •May not be ideal for those prioritizing muscle gain
Purpose & Use Cases
Insulin Sensitivity
Improves whole-body insulin sensitivity through AMPK activation and enhanced GLUT4 activity. Used to counteract insulin resistance from HGH or chronic insulin use.
Blood Sugar Management During Bulking
Helps partition nutrients toward muscle rather than fat during high-carb phases. Manages glucose without hypoglycemia risk.
Longevity/Anti-Aging
Mimics some benefits of calorie restriction. Mouse studies show ~6% lifespan extension. Human TAME trial investigating aging as a treatable indication.
With HGH/Insulin Protocols
Counteracts HGH-induced insulin resistance. Increases effectiveness of exogenous insulin. Often used at 500-800mg 1-2x daily during such protocols.
Benefits
- Improves insulin sensitivity without hypoglycemia risk
- Reduces hepatic glucose production by 9-30%
- May help with body recomposition (mean 5.8kg weight loss in obese subjects)
- Potential longevity benefits (AMPK activation, mTOR modulation)
- Very safe long-term profile (decades of clinical use)
- Reduces cardiovascular disease risk
- Inexpensive and widely available
- Not a controlled substance or WADA prohibited
Good to Know
AMPK is why it is a longevity candidate AND why it can blunt gains
Metformin inhibits mitochondrial Complex I, which activates AMPK (the cell's energy-low sensor). AMPK improves insulin sensitivity and mimics some calorie-restriction/longevity signalling, but it also OPPOSES mTORC1, the pathway that drives muscle protein synthesis. The MASTERS trial (older adults, ~1700mg/day) showed metformin blunted the hypertrophy and strength gains from resistance training. It is the same hormesis nuance as blanket antioxidants: the signal it dampens is part of the growth stimulus.
The longevity story is still unsettled
Mouse data and diabetic-cohort observations look promising, but the human TAME trial has not yet shown metformin extends healthy lifespan in non-diabetics, and some data suggest it can blunt the cardiometabolic and hypertrophy benefits of exercise. Treat "metformin for longevity" as a plausible hypothesis, not settled fact.
It depletes vitamin B12
Up to ~30% of long-term users drop their B12 (it interferes with calcium-dependent B12 uptake in the gut), which can cause neuropathy and anemia over time. Monitor B12 periodically and supplement: this is the one genuinely important ancillary with metformin.
It does not cause hypoglycemia on its own
Unlike insulin or sulfonylureas, metformin lowers hepatic glucose OUTPUT rather than forcing blood sugar down, so used alone it does not cause hypoglycemia. Its main practical use in a PED context is blunting HGH/insulin-induced insulin resistance and managing glucose on high-carb phases.
Dosage Guidelines
| Experience Level | Dosage Range |
|---|---|
| Beginner | 500 – 500 mg/day |
| Intermediate | 500 – 1000 mg/day |
| Advanced | 1000 – 2000 mg/day |
Start at 500mg once daily with food to minimize GI side effects. Increase by 500mg every 1-2 weeks as tolerated. Extended-release formulation (XR) has fewer GI sides. Take with carbohydrate-containing meals. Longevity protocols often use 500-1000mg/day. Some use intermittent dosing (2-3x/week).
The plasma elimination half-life is ~4-8.7 hours; metformin also partitions into red blood cells, giving a much longer blood/RBC compartment half-life of ~17-31 hours.
Side Effects
Gastrointestinal Issues
very commonDiarrhea, nausea, bloating, gas, stomach discomfort in 20-25% of patients. Most common side effect.
Take with meals. Use extended-release (XR) formulation. Start low, titrate slowly. Usually improves over 2-4 weeks.
Vitamin B12 Deficiency
commonUp to 30% of long-term users develop deficiency. Can cause peripheral neuropathy, anemia, cognitive issues.
Annual B12 monitoring recommended. Supplement with methylated B12 (methylcobalamin).
Lactic Acidosis
rareVery rare (3-10 per 100,000 patient-years) but up to 50% mortality when it occurs. Symptoms: rapid breathing, nausea, fatigue, muscle cramps, confusion.
Avoid if renal impairment, liver disease, excessive alcohol, dehydration, or acute illness. Stop before contrast imaging.
Metallic Taste
uncommonSome users report metallic or unpleasant taste.
Usually resolves with time.
Blunted Exercise Adaptations
commonMASTERS trial showed metformin blunted muscle hypertrophy gains from resistance training; separate research links it to dampened aerobic/mitochondrial adaptations. AMPK activation inhibits mTORC1 (key for muscle protein synthesis).
Consider timing around training or intermittent use. May need to weigh benefits vs muscle-building goals.
General Mitigation Strategies
GI side effects are the most common issue - mitigate by starting low, titrating slowly, taking with food, and using XR formulation. B12 supplementation recommended for long-term use. The blunting of exercise adaptations is a significant concern for bodybuilders - consider whether insulin sensitivity benefits outweigh potential muscle gains impact.
Support Supplements
Ancillary supplements commonly run alongside Metformin to manage side effects, support the target tissue, or fill nutrient demands it creates.
Vitamin B12 (methylcobalamin)
KeyMetformin interferes with calcium-dependent B12 absorption in the ileum; up to ~30% of long-term users become deficient, which can cause peripheral neuropathy, anemia and cognitive symptoms over years.
- Dose
- 1,000 mcg/day oral methylcobalamin (or intramuscular injections if frank deficiency)
- Timing
- Daily
- When
- Mainly a concern with long-term use: check serum B12 (and MMA/homocysteine if borderline) roughly annually.
Post Cycle Therapy (PCT)
Does not affect HPT axis. No PCT required. Can be used long-term.
How It Works
Metformin primarily inhibits Complex I of the mitochondrial respiratory chain in the liver, leading to AMPK activation. This suppresses hepatic gluconeogenesis (primary effect), increases peripheral glucose uptake via GLUT4 deployment, reduces intestinal glucose absorption, and improves insulin receptor tyrosine kinase activity. Also inhibits ACC1/ACC2, decreasing hepatic lipogenesis and increasing fat oxidation.
Fundamentals
Reference on the practices relevant to Metformin: how they are done and where they go wrong. Not a recommendation to use it.
Common Stacks
- Metformin + HGH - Counteracts HGH-induced insulin resistance
- Metformin + Insulin - Increases insulin effectiveness, manages resistance
- Metformin + Berberine - Not recommended (similar mechanisms, increased GI issues)
- Consider timing away from training to minimize blunting of adaptations
Legal Status
Prescription medication (USA). FDA-approved for Type 2 diabetes. Not a controlled substance. Not WADA prohibited.
Legal status varies by country and changes over time. This is a general summary, not legal advice.
WADA Status
Metformin is not listed on the WADA Prohibited List. It is an FDA-approved diabetes medication.